Your browser doesn't support javascript.
loading
Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.
Brahmachari, Saurav; Lee, Saebom; Kim, Sangjune; Yuan, Changqing; Karuppagounder, Senthilkumar S; Ge, Preston; Shi, Rosa; Kim, Esther J; Liu, Alex; Kim, Donghoon; Quintin, Stephan; Jiang, Haisong; Kumar, Manoj; Yun, Seung Pil; Kam, Tae-In; Mao, Xiaobo; Lee, Yunjong; Swing, Deborah A; Tessarollo, Lino; Ko, Han Seok; Dawson, Valina L; Dawson, Ted M.
Afiliação
  • Brahmachari S; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Lee S; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Kim S; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.
  • Yuan C; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Karuppagounder SS; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Ge P; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Shi R; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Kim EJ; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Liu A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Kim D; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.
  • Quintin S; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Jiang H; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Kumar M; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.
  • Yun SP; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Kam TI; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Mao X; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.
  • Lee Y; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Swing DA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Tessarollo L; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.
  • Ko HS; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Dawson VL; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Dawson TM; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.
Brain ; 142(8): 2380-2401, 2019 08 01.
Article em En | MEDLINE | ID: mdl-31237944
ABSTRACT
α-Synuclein misfolding and aggregation plays a major role in the pathogenesis of Parkinson's disease. Although loss of function mutations in the ubiquitin ligase, parkin, cause autosomal recessive Parkinson's disease, there is evidence that parkin is inactivated in sporadic Parkinson's disease. Whether parkin inactivation is a driver of neurodegeneration in sporadic Parkinson's disease or a mere spectator is unknown. Here we show that parkin in inactivated through c-Abelson kinase phosphorylation of parkin in three α-synuclein-induced models of neurodegeneration. This results in the accumulation of parkin interacting substrate protein (zinc finger protein 746) and aminoacyl tRNA synthetase complex interacting multifunctional protein 2 with increased parkin interacting substrate protein levels playing a critical role in α-synuclein-induced neurodegeneration, since knockout of parkin interacting substrate protein attenuates the degenerative process. Thus, accumulation of parkin interacting substrate protein links parkin inactivation and α-synuclein in a common pathogenic neurodegenerative pathway relevant to both sporadic and familial forms Parkinson's disease. Thus, suppression of parkin interacting substrate protein could be a potential therapeutic strategy to halt the progression of Parkinson's disease and related α-synucleinopathies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas Repressoras / Ubiquitina-Proteína Ligases / Alfa-Sinucleína Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas Repressoras / Ubiquitina-Proteína Ligases / Alfa-Sinucleína Idioma: En Ano de publicação: 2019 Tipo de documento: Article